Neurogene Inc.

About Neurogene Inc.

Neurogene is a clinical-stage company focused on developing life-changing genetic medicines for individuals and families affected by devastating neurological diseases. Their mission is to advance gene therapy through innovation, robust scientific execution, and a strong sense of purpose.

Products & Services

Gene Therapy Pipeline:A range of gene therapy treatments targeting rare neurological diseases, addressing high unmet medical needs.

NGN-401 Gene Therapy:A specific gene therapy for Rett syndrome, with the Embolden™ registrational clinical trial design announced and initiation activities underway.

EXACT Technology:A proprietary technology platform used in the development of genetic medicines.

Specialties

Genetic Medicines Gene Therapy Neurological Diseases Clinical Trials EXACT Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Investment in Public Equity (PIPE) T: - FT: Private Investment in Public Equity (PIPE)	A: 200000000 MR: - FA: $200 million FAN: 200000000	D: 2024-11-04 FD: 2024-11-04	8 investors

Private Investment in Public Equity (PIPE) Latest

2024-11-04

$200.0M

8 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Rachel McMinn

Founder and Chief Executive Officer

C

Christine Mikail

President and Chief Financial Officer

S

Stuart Cobb

Chief Scientific Officer

J

Julie Jordan

Chief Medical Officer

E

Effie Albanis

Senior Vice President, Early Clinical and Translational Research

A

Andrew Mulberg

Senior Vice President, Regulatory Affairs, Quality Assurance, and Quality Control

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

Neurogene Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised